Distribution Practices for Retail Note Offerings
Distribution Practices for Retail Note Offerings
Structured notes reach retail investors through a distribution network involving issuers, distributors, and financial advisors. Understanding distribution practices helps investors evaluate products, assess conflicts of interest, and ensure they receive appropriate recommendations.
Definition and Key Concepts
Distribution Chain
| Participant | Role |
|---|---|
| Issuer | Designs product, issues securities, bears credit risk |
| Arranger | Structures terms, manages issuance process |
| Distributor | Sells to end investors (broker-dealers) |
| Financial advisor | Recommends products to clients |
| Investor | Purchases and holds notes |
Distribution Models
| Model | Description | Typical Products |
|---|---|---|
| Open architecture | Multiple distributors per issuer | Standard structured notes |
| Exclusive distribution | Single distributor relationship | Custom products |
| Direct | Issuer sells directly | Online platforms |
| Wrapped | Via insurance or fund wrapper | Variable annuities |
Compensation Structure
| Fee Type | Recipient | Typical Range |
|---|---|---|
| Distribution fee | Distributor | 0.5-2.0% |
| Sales credit | Financial advisor | 0.3-1.5% |
| Trailing commission | Advisor (ongoing) | 0.1-0.5% p.a. |
| Structuring fee | Arranger | 0.25-0.75% |
How It Works in Practice
Product Origination
Step 1: Identify market opportunity
- Investor demand (yield, protection, specific exposure)
- Market conditions (volatility, interest rates)
- Issuer capacity (credit, balance sheet)
Step 2: Design product
- Select underlying(s)
- Set payoff terms (coupon, barrier, tenor)
- Price embedded options
- Determine issuer economics
Step 3: Prepare documentation
- Prospectus supplement
- Pricing supplement
- Marketing materials
- KID (for EU distribution)
Distribution Process
Pre-sale activities:
| Activity | Responsible Party | Timing |
|---|---|---|
| Product due diligence | Distributor | Before approval |
| Suitability framework | Distributor | Before marketing |
| Training | Issuer/distributor | Before marketing |
| Client identification | Advisor | Ongoing |
Sales period:
| Day | Activity |
|---|---|
| T-5 | Announce offering, distribute preliminary terms |
| T-3 | Marketing to advisors and clients |
| T-1 | Final pricing |
| T | Trade date, allocations |
| T+3 | Settlement, delivery |
Suitability Assessment
Client factors to evaluate:
| Factor | Assessment |
|---|---|
| Investment objective | Growth, income, hedging |
| Risk tolerance | Conservative to aggressive |
| Time horizon | Match to note tenor |
| Liquidity needs | Can hold to maturity? |
| Net worth | Appropriate concentration? |
| Experience | Understands product? |
Documentation requirements:
| Document | Purpose |
|---|---|
| Client profile | Record investor characteristics |
| Suitability rationale | Explain why product fits |
| Risk disclosure | Confirm client understands risks |
| Approval | Supervisor sign-off |
Worked Example
Structured Note Distribution
Product: 18-month auto-callable note on S&P 500
- Issuer: Major bank
- Coupon: 10% p.a. (contingent)
- Auto-call: 100% of initial
- Barrier: 75%
- Principal: At risk below barrier
Distribution economics:
| Component | Amount |
|---|---|
| Issue price to investor | $1,000 |
| Distribution fee | $15 (1.5%) |
| Advisor sales credit | $10 (1.0%) |
| Trailing (if applicable) | $0 |
| Net proceeds to issuer | $975 |
Allocation example:
| Firm | Indication | Allocation | % of Deal |
|---|---|---|---|
| Firm A | $50M | $40M | 40% |
| Firm B | $30M | $25M | 25% |
| Firm C | $20M | $18M | 18% |
| Firm D | $15M | $12M | 12% |
| Others | $10M | $5M | 5% |
| Total | $125M | $100M | 100% |
Suitability Case Study
Client profile:
- Age: 65, retired
- Net worth: $2 million
- Investment objective: Income
- Risk tolerance: Moderate
- Time horizon: 5+ years
- Current portfolio: 60% bonds, 40% equities
Product consideration: Auto-callable note (above)
Suitability analysis:
| Factor | Assessment |
|---|---|
| Objective match | ✓ Income objective aligns with 10% coupon |
| Risk match | ⚠ Barrier risk may exceed moderate tolerance |
| Horizon | ✓ 18 months fits within 5+ year horizon |
| Liquidity | ✓ Sufficient other liquid assets |
| Concentration | ✓ <5% of portfolio in structured products |
| Understanding | ⚠ Needs clear explanation of barrier risk |
Recommendation decision: Suitable with enhanced disclosure on barrier risk. Document client's understanding of potential principal loss.
Conflict Disclosure
Required disclosures:
| Conflict | Disclosure |
|---|---|
| Compensation | "We receive 1.5% from issuer" |
| Issuer relationship | "We are affiliated with issuer" |
| Market making | "We may make a market in this security" |
| Proprietary trading | "We may trade for our own account" |
| Research | "Our research may differ from this recommendation" |
Risks, Limitations, and Tradeoffs
Distribution Risks
| Risk | Description |
|---|---|
| Mis-selling | Product sold to unsuitable investors |
| Disclosure failure | Material information not communicated |
| Conflict | Compensation influences recommendations |
| Supervision | Inadequate oversight of advisors |
Investor Considerations
| Issue | Impact |
|---|---|
| Illiquidity | May not be able to sell before maturity |
| Pricing opacity | Secondary market prices may differ from fair value |
| Issuer credit | Note becomes worthless if issuer defaults |
| Complexity | May not fully understand product |
| Costs | Embedded costs reduce returns |
Common Pitfalls
| Pitfall | Description | Prevention |
|---|---|---|
| Overconcentration | Too much in structured products | Portfolio limits |
| Wrong tenor | Note doesn't match liquidity needs | Align horizons |
| Misunderstood risk | Client surprised by losses | Clear disclosure |
| Comparison shopping | Not comparing to alternatives | Show alternatives |
| Ignoring fees | Hidden costs not considered | Full cost analysis |
Best Practices
For Distributors
| Practice | Description |
|---|---|
| Product due diligence | Thoroughly review before approval |
| Advisor training | Ensure advisors understand products |
| Supervision | Monitor sales and suitability |
| Documentation | Maintain complete records |
| Complaint handling | Address issues promptly |
For Advisors
| Practice | Description |
|---|---|
| Know your product | Understand all features and risks |
| Know your client | Maintain current profiles |
| Document recommendations | Record rationale |
| Disclose conflicts | Transparent about compensation |
| Follow up | Monitor client holdings |
For Investors
| Practice | Description |
|---|---|
| Read documents | Review prospectus, not just marketing |
| Ask questions | Understand what you're buying |
| Compare alternatives | Consider simpler options |
| Assess issuer | Consider credit risk |
| Plan for illiquidity | Don't invest needed funds |
Regulatory Focus Areas
Current Enforcement Priorities
| Area | Focus |
|---|---|
| Suitability | Documentation and process |
| Disclosure | Clear, balanced presentation |
| Supervision | Firm oversight effectiveness |
| Conflicts | Compensation transparency |
| Concentration | Overexposure to single products |
Remediation Examples
| Issue | Remediation |
|---|---|
| Inadequate disclosure | Investor notification, offer to rescind |
| Suitability failure | Review impacted accounts, compensation |
| Supervision gaps | Enhanced procedures, monitoring |
| Training deficiency | Mandatory retraining |
Checklist and Next Steps
Distributor checklist:
- Complete product due diligence
- Approve for distribution
- Train advisors
- Establish supervision procedures
- Set concentration limits
- Monitor sales activity
Advisor checklist:
- Understand product fully
- Update client profile
- Assess suitability
- Document recommendation rationale
- Deliver required disclosures
- Obtain principal approval
Investor checklist:
- Read prospectus and pricing supplement
- Understand all risks
- Assess issuer credit quality
- Compare to alternatives
- Ensure liquidity needs are met
- Consider portfolio concentration
Related articles:
- For regulations, see Regulatory Considerations for Structured Products
- For Monte Carlo valuation, see Valuing Exotics with Monte Carlo Methods